Persistent pruritus after hydroxyethyl starch infusion therapy: A result of long-term storage in cutaneous nerves

British Journal of Dermatology

Volumn 136, Issue 4, 1997, Pages 553-559

  Metze, D ^a   Reimann, S ^a   Szepfalusi, Z ^b   Bohle, B ^b   Kraft, D ^b   Luger, T A ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

HETASTARCH;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL VACUOLE; ELECTRON MICROSCOPY; FEMALE; HUMAN; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION; PRIORITY JOURNAL; PRURITUS; SKIN BIOPSY;

EID: 0030892813     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb02140.x     Document Type: Article

References (35)

1. Hulse JD, Yacobi A. Hetastarch: An overview of the colloid and its metabolism. Drug Intell Clin Pharm 1983; 17: 334-41.
2. Nakasato SK. Evaluation of hetastarch. Clin Pharm 1982; 1: 509-14.
3. Messmer K, Kreimeier U, Intaglietta M. Present state of intentional hemodilution. Eur Surg Res 1986; 18: 254-63.
4. Kiesewetter H, Blume J, Jung F et al. Haemodilution with medium molecular weight hydroxyethyl starch in patients with peripheral arterial occlusive disease stage IIb. J Intern Med 1990; 227: 107-14.
5. Wilhelm HJ, Jung F, Kiesewetter H, Recktenwald C. On haemodilution therapy for patients with sudden loss of hearing: clinical and rheological results. Klin Wochenschr 1986; 64: 1058-61.
6. Kroemer H, Haass A, Muller K et al. Hemodilution therapy in ischemic stroke: plasma concentrations and plasma viscosity during long term infusion of dextran 40 or hydroxyethyl starch 200/0.5. Eur J Clin Pharmacol 1987; 31: 705-10.
7. Parker NE, Porter JB, Williams HJM, Leftley N. Pruritus after administration of hetastarch. Br Med J 1982; 284: 385-6.
8. Richter W, Hedin H. Solutions and emulsions used for intravenous infusions. In: Handbook of Experimental Pharmacology (Weck AL de, Bungaard H, eds), Vol. 63. Berlin: Springer-Verlag, 1983; 581-628.
9. Förster H. Pharmakologie von Hydroxyethylstärke. Verweildauer, Kinetik und klinische Schluβfolgerungen. In: Hydroxyethylstärke. Eine aktuelle Übersicht (Lawin P, Zander J, Weidler B, eds). Stuttgart: Thieme Verlag, 1989; 15-27.
10. Kraft D, Sirtl C, Laubenthal H et al. No evidence for the existence of preformed antibodies against hydroxyethyl starch in man. Eur Surg Res 1992; 24: 138-42.
11. Kreimeier U, Christ F, Kraft D et al. Anaphylaxis due to hydroxyethyl-starch-reactive antibodies. Lancet 1995; 546: 49-50.
12. Hong B, Zhang T. Studies on the side-effect of hydroxyethyl starch. Pharmacology 1988; 108: 43.
13. Schneeberger R, Albegger K, Oberascher G, Miller K. Juckreiz-Eine Nebenwirkung von Hydroxyäthylstärke (HES)? Erste Mittilung HNO 1990; 38: 298-303.
14. Kiesewetter. Diskussionsbeitrag. In: Hydroxyäthylstärke. Eine aktuelle Übersicht (Lawin P, Zander J, Weidler B, eds). Stuttgart: Thieme Verlag, 1989; 26.
15. Gall H, Kaufmann R, von Ehr M et al. Persistierender Pruritus nach Hydroxyethylstärke-Infusionen. Hautarzt 1993; 44: 713-16.
16. Gallenkemper G, Ulrich R. Therapie von Pruritus und Urtikaria factitia nach Hydroxyäthylstärke-Infusionen. Fallbericht und Revision der Literatur. Z Hautkrankh 1992; 67: 353-8.
17. Förster H, Wicarkzyk C, Dudziak R. Bestimmung der Plasmaelimination von Hydroxyaethylstärke und von Dextran mittels verbesserter analytischer Methodik. Infusionsther Klin Ernahr 1981; 8: 88-94.
18. Banks w, Greenwood CT, Muir DD. The structure of hydroxyethyl starch. Br j Pharmacol 1973; 47: 172-8.
19. Köhler H, Zschiedrich H, Linfante A et al. Die Elimination von Hydroxyethylstärke 200/0.5, Dextran 40 und Oxypolygelantine. Klin Wochenschr 1982; 60: 293-301.
20. Sirtl C, Hübner G, Jesch F. Zur Speicherung von hoch- und mittel-molekularer Hydroxyäthylstärke (HÄS) im menschlichen Gewebe. Beitr Anaesth Intensivmed 1988; 26: 74-97.
21. Jurecka W, Szepfalusi Z, Parth E et al. Hydroxyethylstarch deposits in human skin - a model for pruritus? Arch Dermatol Res 1993; 285: 13-19.
22. Richter AW, deBelder AN. Antibodies against hydroxyethylstarch produced in rabbits by immunization with a protein hydroxyethylstarch conjugate. Int Arch Allergy Appl Immunol 1976; 52: 307-14.
23. Romano EL, Romano M. Staphylococcal protein A bound to colloidal gold: a useful reagent to label antigen - antibody sites in electron microscopy. Immunochemistry 1977; 14: 711-15.
24. Thompson WL, Fukushima T, Rutherford RB, Walton RB. Intravascular persistence, tissue storage and excretion of hydroxyethyl starch. Surg Gynecol Obstet 1970; 131: 965-72.
25. Paulini K, Sonntag W. Veränderungen der RHS der Ratte nach parenteraler Gabe von Dextran (Mw 40.000) und Hydroxyäthylstärke (Mw 40.000). Chemische, licht-und elektronenmikroskopische untersuchungen. Infusionstherapie 1976; 3: 294-9.
26. Parth E, Jurecka W, Szepfalusi Z et al. Histological and immunohistochemical investigations of hydroxyethylstarch deposits in rat tissues. Eur Surg Res 1992; 24: 13-21.
27. Szépfalusi Z, Parth E, Jurecka W et al. Human monocytes and keratinocytes in culture ingest hydroxyethylstarch. Arch Dermatol Res 1993; 285: 144-50.
28. Kiehl P, Reimann S, Schiljaewa et al. Persistent periocular swelling after infusion of hydroxyethyl starch (HES) in a patient with decreased activity of acid alpha-glucosidase. J Invest Dermatol 1994; 103: 261 (Abstr).
29. Breathnach AS. Electron microscopy of cutaneous nerves and receptors. J Invest Dermatol 1977; 69: 8-26.
30. Hägermark Ö, Wahlgren CF. Some methods for evaluating clinical itch and their application for studying pathophysiological mechanisms. J Dermatol Sci 1992; 4: 55-62.
31. Denman ST. A review of pruritus. J Am Acad Dermatol 1986; 14: 375-92.
32. Wong RC, Fairley JA, Ellis CN. Dermographism: a review. J Am Acad Dermatol 1984; 11: 643-52.
33. Szeimies RM, Stolz W, Wlotzke U et al. Successful treatment of hydroxyethyl starch-induced pruritus with topical capsaicin. Br J Dermatol 1994; 131: 380-2.
34. Fartasch M, Anton-Lamprecht I, Frosch PJ, Petzoldt D. Polyvinylpyrrolidon-Dermatose. Klinik und ultrastrukturelle morphologie. Hautarzt 1988; 39: 569-75.
35. Thivolet J, Leung TK, Duverne J et al. Ultrastructural morphology and histochemistry (acid phosphatase) of the cutaneous infiltration by polyvinylpyrrolidone. Br J Dermatol 1970; 83: 661-9.